Endoscopic Retrograde Cholangiopancreatography Access and Complication Rates After Cholecystectomy With Common Bile Duct Stones
Complication Rates Associated With Access or Not to Endoscopic Retrograde Cholangiopancreatography (ERCP) in Units Performing Cholecystectomy, When Common Bile Duct Stones Are Detected on Intraoperative Cholangiography
調査の概要
詳細な説明
Annually, approximately 15,000 cholecystectomies are performed in Sweden. Cholecystectomy is indicated if gallstones cause recurrent biliary colic or complications. Gallstones can pass from the gallbladder into the common bile duct. Common bile duct stones (CBDS) can potentially cause biliary obstruction, cholangitis and pancreatitis.
Intraoperative cholangiography (IOC) during cholecystectomy is performed as a standard in Swedish surgical units. The arguments for routine IOC are several; routine IOC is associated with reduced risk of bile duct injury in patients with previous or ongoing cholecystitis, early detection of bile duct injury has been suggested to improve survival, and CBDS found by IOC, even small ones <4 mm, are associated with increased risk of complications and need for unplanned endoscopic retrograde cholangiopancreatography (ERCP) if no effort is made to clear the common bile duct.
American guidelines suggest performing IOC as a routine in adult patients undergoing laparoscopic cholecystectomy. Many countries do not practice routine IOC because it prolongs cholecystectomy and the evidence supporting its use is considered insufficient. European guidelines do not include routine IOC as a recommendation. On the other hand, both American and European guidelines advocate treatment of all CBDS, symptomatic or not.
CBDS represent a well-recognized clinical dilemma, especially when encountered first on IOC during cholecystectomy. In those situations, intraoperative treatment of CBDS has not been planned in advance.
There are several different approaches to remove CBDS. Worldwide, the two most common methods used are preoperative endoscopic retrograde cholangiopancreatography (ERCP) followed by cholecystectomy, or laparoscopic exploration of the common bile duct during cholecystectomy. In Sweden, the predominant treatment strategy for CBDS encountered on IOC is intraoperative ERCP.
The ERCP procedure itself is associated with a non-negligible risk of complications. The most common, and potentially severe, complication is post-ERCP pancreatitis (PEP). According to observational studies based on data from the Swedish Registry for Gallstone Surgery and ERCP (GallRiks), rendezvous-ERCP is associated with less complications, mainly PEP, compared to postoperative rendezvous-ERCP, and rendezvous-ERCP reduces the risk of PEP compared to conventional ERCP.
There are major differences between Swedish regions in the treatment of gallstone disease and outcome, probably because of different local routines. All units in Sweden performing cholecystectomies must be able to handle CBDS encountered at IOC, according to the national guidelines. The same guidelines advocate intraoperative ERCP with the rendezvous technique. ERCP volumes differ greatly between different surgical units in Sweden and the proportion of units performing ERCP has decreased over time. Smaller volumes of ERCP per surgeon are associated with more complications, including PEP.
In Sweden, part of the gallbladder surgery has moved from emergency care hospitals to elective, and sometimes private units, over the last few decades. Some of these units lack the equipment or expertise necessary for ERCP. Thus, despite what current national guidelines recommend, patients undergoing cholecystectomy, with a finding of CBDS on IOC, do not have the option to be treated with intra- or postoperative ERCP in such a surgical unit. Their CBDS must be treated in another way intraoperatively or with postponed ERCP after transfer to another unit.
How these structural differences in ERCP access at cholecystectomy affect the type of treatment of CBDS, time to treatment of CBDS, and thus complications, is not investigated. Because alternative treatment strategies to ERCP are used in units without access to ERCP, but also in units with access to ERCP, this question cannot simply be answered by the difference in complications from intra- and postoperative ERCP. Furthermore, these other strategies do not necessarily have a higher risk of complications compared to ERCP.
In a previous study, based on data from GallRiks, laparoscopic cholecystectomy with intraoperative rendezvous ERCP was associated with more complications compared to laparoscopic cholecystectomy with transcystic stent and postoperative ERCP.
The intention is to study how access to ERCP in different units affect complication rates in patients undergoing cholecystectomy when CBDS are detected on IOC. If the study shows no difference in risk of complications, there is a future possibility to transfer more gallbladder surgery out of emergency care hospitals and to enable more capacity for emergency surgery. On the other hand, if the study shows an increased risk of complications if the procedure is performed in a surgical unit without access to ERCP, there is an argument to transfer patients the other way around or establish capacity for ERCP at a greater number of hospitals.
Research question In patients undergoing laparoscopic cholecystectomy with CBDS on IOC, is there a difference in complication rates depending on access or not to ERCP at the surgical unit?
Aim and hypothesis The aim of this retrospective, register-based study is to investigate whether access, or no access, to ERCP at a surgical unit is associated with the risk of complications in patients undergoing laparoscopic cholecystectomy with CBDS detected on IOC.
The hypothesis is that laparoscopic cholecystectomy with CBDS on IOC in units with access to ERCP will be associated with less complications compared to units without access to ERCP.
PICO P Patients, ≥18 years old, undergoing laparoscopic cholecystectomy with CBDS detected on IOC in Sweden 2015-2025 and registered in GallRiks.
I There is no specific intervention performed in each group. Instead, patients undergoing cholecystectomy at a unit without access to ERCP are considered as exposed individuals.
C Patients undergoing cholecystectomy at a unit with access to ERCP are considered unexposed, serving as controls.
O Primary outcome is complications within 30 days. Complications from both the cholecystectomy and the ERCP, if performed, will be considered since the entire course of care is important from a safety perspective.
Data will be analyzed separately for acute and elective gallbladder procedures, as units without access to ERCP perform elective surgery to a very large extent.
Sweden has a distinctive approach to manage CBDS, and a nationwide register for gallbladder surgery and ERCP, GallRiks. When validated, GallRiks has shown high completeness and high correctness of entered data. Taken together, this provides a unique possibility to contribute to research in gallbladder surgery.
Primary outcome Complications
Secondary outcomes Length of hospital stay, time from surgery to first treatment of common bile duct stones, unplanned ERCP after surgery due to CBDS, mortality
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Sara Johansson
- 電話番号:+46727362315
- メール:snnsjohan@gmail.com
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- ≥18 years old
- Laparoscopic cholecystectomy with common bile duct stones (CBDS) detected on intraoperative cholangiography (IOC)
- Procedure registered in the Swedish Registry for Gallstone Surgery and ERCP (GallRiks) 2015-2025
Exclusion Criteria:
- Open surgery
- Conversion to open surgery
- Transgastric ERCP
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Cholecystectomy without access to endoscopic retrograde cholangiopancreatography (ERCP)
Patients, ≥18 years old, undergoing laparoscopic cholecystectomy with CBDS detected on IOC in Sweden 2015-2025 and registered in GallRiks.
The cholecystectomy is performed in a unit without access to ERCP.
|
The exposed group consists of patients undergoing laparoscopic and diagnosed with CBDS during cholecystectomy at a unit where ERCP is not available.
|
|
Cholecystectomy with access to ERCP
Patients, ≥18 years old, undergoing laparoscopic cholecystectomy with CBDS detected on IOC in Sweden 2015-2025 and registered in GallRiks.
The cholecystectomy is performed in a unit with access to ERCP.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Complications
時間枠:0- 30 days from the cholecystectomy, 0-30 days from any performed ERCP
|
Overall complications from both the cholecystectomy and the endoscopic retrograde cholangiopancreatography (ERCP).
|
0- 30 days from the cholecystectomy, 0-30 days from any performed ERCP
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Length of hospital stay
時間枠:0-100 days from the cholecystectomy, 0-100 days from any performed ERCP
|
Length of hospital stay for cholecystecomy plus ERCP
|
0-100 days from the cholecystectomy, 0-100 days from any performed ERCP
|
|
Time from cholecystectomy to first treatment of common bile duct stones
時間枠:0-100 days from the cholecystectomy
|
Time from cholecystectomy to first treatment of common bile duct stones (days)
|
0-100 days from the cholecystectomy
|
|
Unplanned ERCP after surgery due to CBDS
時間枠:1-365 days
|
Unplanned ERCP after treatment of CBDS
|
1-365 days
|
|
Unplanned readmission
時間枠:0- 30 days from the cholecystectomy, 0-30 days from any performed ERCP
|
Unplanned readmission (yes or no)
|
0- 30 days from the cholecystectomy, 0-30 days from any performed ERCP
|
|
Mortality
時間枠:0-30 days from the cholecystectomy, 0-30 days from any performed ERCP
|
Mortality
|
0-30 days from the cholecystectomy, 0-30 days from any performed ERCP
|
協力者と研究者
スポンサー
出版物と役立つリンク
一般刊行物
- Moller M, Gustafsson U, Rasmussen F, Persson G, Thorell A. Natural course vs interventions to clear common bile duct stones: data from the Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks). JAMA Surg. 2014 Oct;149(10):1008-13. doi: 10.1001/jamasurg.2014.249.
- Rystedt J, Montgomery A, Persson G. Completeness and correctness of cholecystectomy data in a national register--GallRiks. Scand J Surg. 2014 Dec;103(4):237-44. doi: 10.1177/1457496914523412. Epub 2014 Apr 15.
- Johansson S, Runfors C, Sandblom G, Lindkvist B, Thorell A, Reuterwall Hansson M. Laparoscopic transcystic stenting with postoperative ERCP for the treatment of common bile duct stones: a safe alternative to intraoperative rendezvous ERCP-Data from the Swedish registry for gallstone surgery and ERCP (GallRiks). Surg Endosc. 2026 Jan 21;40(4):3040-7. doi: 10.1007/s00464-026-12565-3. Online ahead of print.
- Syren EL, Sandblom G, Enochsson L, Eklund A, Isaksson B, Osterberg J, Eriksson S. Outcome of ERCP related to case-volume. Surg Endosc. 2022 Jul;36(7):5339-5347. doi: 10.1007/s00464-021-08915-y. Epub 2022 Jan 3.
- Swahn F, Nilsson M, Arnelo U, Lohr M, Persson G, Enochsson L. Rendezvous cannulation technique reduces post-ERCP pancreatitis: a prospective nationwide study of 12,718 ERCP procedures. Am J Gastroenterol. 2013 Apr;108(4):552-9. doi: 10.1038/ajg.2012.470. Epub 2013 Feb 19.
- Noel R, Arnelo U, Swahn F. Intraoperative versus postoperative rendezvous endoscopic retrograde cholangiopancreatography to treat common bile duct stones during cholecystectomy. Dig Endosc. 2019 Jan;31(1):69-76. doi: 10.1111/den.13222. Epub 2018 Jul 24.
- Tornqvist B, Stromberg C, Persson G, Nilsson M. Effect of intended intraoperative cholangiography and early detection of bile duct injury on survival after cholecystectomy: population based cohort study. BMJ. 2012 Oct 11;345:e6457. doi: 10.1136/bmj.e6457.
- Tornqvist B, Stromberg C, Akre O, Enochsson L, Nilsson M. Selective intraoperative cholangiography and risk of bile duct injury during cholecystectomy. Br J Surg. 2015 Jul;102(8):952-8. doi: 10.1002/bjs.9832. Epub 2015 Apr 28.
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。